TWD
LENZ

True Wealth Design’s LENZ Therapeutics LENZ Stock Holding History

True Wealth Design’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27K Buy
224
+176
+367% +$1.42K ﹤0.01% 1889
2026
Q1 		$440 Buy
+48
New +$674 ﹤0.01% 2101
2025
Q4 		– Sell
-15
Closed -$699 – 2865
2025
Q3 		$699 Buy
15
+11
+275% +$404 ﹤0.01% 1889
2025
Q2 		$118 Hold
4
– – ﹤0.01% 2199
2025
Q1 		$103 Buy
+4
New +$99 ﹤0.01% 2183

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

True Wealth Design's LENZ Position: Q2 2026 in Review

True Wealth Design increased its LENZ Therapeutics (LENZ) stake by 367% in Q2 2026, buying an estimated $1.42K and bringing the position to 224 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1889.

True Wealth Design first reported a position in LENZ in Q1 2025 and has held it in 5 quarters since. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • True Wealth Design held 224 shares of LENZ Therapeutics worth $1.27K as of Q2 2026.
  • True Wealth Design bought 176 LENZ Therapeutics shares in Q2 2026, an estimated $1.42K.
  • LENZ Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1889 holding.
  • True Wealth Design first reported a position in LENZ Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.